CAS: 1206163-45-2
Ref: IN-DA008TN5
| 5mg | 56,00 € | ||
| 10mg | 92,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Solcitinib
CAS:1206163-45-2
Solcitinib (GLPG-0778), a JAK1 inhibitor, may treat psoriasis, ulcerative colitis, and lupus.
Fórmula:
C22H23N5O2
Pureza:
98.25% - 99.82%
Forma y color:
Solid
Peso molecular:
389.45
Ref: TM-T3620
| 5mg | 50,00 € | ||
| 10mg | 62,00 € | ||
| 25mg | 88,00 € | ||
| 50mg | 113,00 € | ||
| 100mg | 181,00 € | ||
| 200mg | 291,00 € | ||
| 1mL*10mM (DMSO) | 50,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
![N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropan...](https://static.cymitquimica.com/products/10/thumb/F497231.jpg)
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
CAS:1206163-45-2
Pureza:
95.0%
Peso molecular:
389.4590148925781
Ref: 10-F497231
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
Solcitinib
CAS:1206163-45-2
Solcitinib is a Jak1 inhibitor that is being evaluated for its potential to treat cancer. …
Fórmula:
C22H23N5O2
Pureza:
Min. 95%
Peso molecular:
389.45 g/mol
Ref: 3D-GYB16345
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
